← Back to Search

Behavioural Intervention

AI-Powered Device for Chronic Insomnia in Cancer Survivors

N/A
Recruiting
Research Sponsored by Medstar Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing an AI-powered device to help young adult cancer survivors with chronic sleep disorders using cognitive behavioral therapy. #CBTI #VAVA #SleepDisorders

Who is the study for?
This trial is for young adult cancer survivors aged 18-29 who suffer from chronic insomnia. Participants must have a history of any type or stage of cancer and an internet router at home. They should be experiencing less sleep than recommended for their age over the past 3 months. Those with acute medical/psychiatric disorders, developmental disorders, or a life expectancy under 12 months cannot join.
What is being tested?
The study is testing the VAVA prototype, a voice-activated virtual assistant designed to deliver Cognitive Behavioral Therapy for Insomnia (CBT-I). The goal is to see if this device can help improve sleep among young adults who survived cancer and are struggling with chronic sleep issues.
What are the potential side effects?
Since the intervention involves using a virtual assistant device to provide therapy, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Feasibility of device use

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention armExperimental Treatment1 Intervention
Participants (N=15) will will be provided with the VAVA prototype along with installation instructions to embed the VAVA within their homes. We provide them with a smart speaker running our intervention, a smart lamp, and a new router. They will be asked to trial the VAVA for a period of 2 weeks, a duration consistent with the primary stage of CBT-I treatment.

Find a Location

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor
197 Previous Clinical Trials
186,056 Total Patients Enrolled

Media Library

VAVA prototype (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05875129 — N/A
Cancer Research Study Groups: Intervention arm
Cancer Clinical Trial 2023: VAVA prototype Highlights & Side Effects. Trial Name: NCT05875129 — N/A
VAVA prototype (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05875129 — N/A
~6 spots leftby Dec 2025